Background: Metabolic syndrome (MetS) is a cluster of disorders with a high incidence which can lead to the development of type 2 diabetes mellitus and cardiovascular disease. Chronic low-grade inflammation has been implicated in the development of metabolic syndrome. Inflammatory markers such as C-reactive protein have been proved to be associated with MetS, but they are often used in disease diagnosis rather than in routine health screening. Instead, leukocyte is a convenient inflammatory marker. However, the association between leukocyte-related parameters and MetS remains unclear. Therefore, we aimed to perform a systematic review and meta-analysis to evaluate the association between leukocyte parameters and MetS. Materials and Methods: PubMed, EMBASE, Cochrane, and Web of Science were searched for articles published from September 2012 to September 2022 for studies on the association of leukocyte with MetS patients. Outcome data were extracted and the standardized mean difference (SMD) and 95% confidence interval (CI) were calculated. STATA software version 16.0 was utilized to conduct meta-analyses and assess publication bias. Results: A literature search of all major databases retrieved 2661 studies. After screening, 11 studies were analyzed including a total of 13301 MetS patients. Pooled analysis showed that elevated leukocyte level was significantly associated with MetS (SMD = 0.31, 95% CI (0.23-0.38), Z = 8.07, P <0.001). Conclusion: Elevated leukocyte level may be a potentially useful clinical marker for predicting the possibility of developing MetS in healthy populations.
| Published in | Central African Journal of Public Health (Volume 10, Issue 2) |
| DOI | 10.11648/j.cajph.20241002.13 |
| Page(s) | 80-89 |
| Creative Commons |
This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited. |
| Copyright |
Copyright © The Author(s), 2024. Published by Science Publishing Group |
Metabolic Syndrome, Inflammation, Leukocyte, Meta-Analysis
| [1] | Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA, 2001, 285(19): 2486-97. https://doi.org/10.1001/jama.285.19.2486 |
| [2] | S. M. Grundy, J. I. Cleeman, S. R. Daniels, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005, 112(17), 2735-2752. https://doi.org/10.1161/CIRCULATIONAHA.105.169404 |
| [3] | M. G. Saklayen, The Global Epidemic of the Metabolic Syndrome. Current Hypertension Reports. 2018, 20(2): 12. https://doi.org/10.1007/s11906-018-0812-z |
| [4] | G. Hirode and R. J. Wong, Trends in the Prevalence of Metabolic Syndrome in the United States, 2011-2016. JAMA. 2020, 323(24): 2526-2528. https://doi.org/10.1001/jama.2020.4501 |
| [5] | F. Yao, Y. Bo, L. Zhao, et al., Prevalence and Influencing Factors of Metabolic Syndrome among Adults in China from 2015 to 2017. Nutrients. 2021, 13(12): 4475. https://doi.org/10.3390/nu13124475 |
| [6] | P. Libby, P. M. Ridker and A. Maseri, Inflammation and atherosclerosis. Circulation. 2002, 105: 1135-1143. https://doi.org/doi.org/10.1161/hc0902.104353 |
| [7] | K. Eguchi and R. Nagai. Islet inflammation in type 2 diabetes and physiology. The Journal of Clinical Investigation. 2017, 127(1): 14-23. https://doi.org/10.1172/JCI88877 |
| [8] | B. W. Wong, A. Meredith, D. Lin and B. M. McManus. The biological role of inflammation in atherosclerosis. The Canadian Journal of Cardiology. 2012, 28(6): 631-641. https://doi.org/10.1016/j.cjca.2012.06.023 |
| [9] | S. Devaraj, U. Singh and I. Jialal, Human C-reactive protein and the metabolic syndrome. Current Opinion In Lipidology. 2009, 20 20(3): 182-189. https://doi.org/10.1097/MOL.0b013e32832ac03e |
| [10] | N. Ishizaka, Y. Ishizaka, E.-I. Toda, et al. Association between cigarette smoking, white blood cell count, and metabolic syndrome as defined by the Japanese criteria. Internal Medicine (Tokyo, Japan). 2007, 46(15): 1167-1170. https://doi.org/10.2169/internalmedicine.46.0136 |
| [11] | J. T. Park, T. I. Chang, D. K. Kim, et al. Association of white blood cell count with metabolic syndrome in patients undergoing peritoneal dialysis. Metabolism: Clinical and Experimental. 2009, 58(10): 1379-1385. https://doi.org/10.1016/j.metabol.2009.05.002 |
| [12] | C.-H. Jung, W.-Y. Lee, B.-Y. Kim, et al. The risk of metabolic syndrome according to the white blood cell count in apparently healthy Korean adults. Yonsei Medical Journal. 2013, 54(3): 615-620. https://doi.org/10.3349/ymj.2013.54.3.615 |
| [13] | E. Buyukkaya, M. F. Karakas, E. Karakas, A. B. Akçay, I. H. Tanboga, M. Kurt, et al. Correlation of neutrophil to lymphocyte ratio with the presence and severity of metabolic syndrome. Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis. 2014, 20(2): 159-63. https://doi.org/10.1177/1076029612459675 |
| [14] | H. Liu, C.-H. Hsu, J.-D. Lin, et al. Predicting metabolic syndrome by using hematogram models in elderly women. Platelets. 2014, 25(2): 97-101. https://doi.org/10.3109/09537104.2013.780017 |
| [15] | A. Maleki, N. Rashidi, H. Aghaei Meybodi, et al. Metabolic syndrome and inflammatory biomarkers in adults: a population-based survey in Western region of iran. International Cardiovascular Research Journal. 2014, 8(4): 156-160. |
| [16] | C. Pei, J.-B. Chang, C.-H. Hsieh, et al. Using white blood cell counts to predict metabolic syndrome in the elderly: A combined cross-sectional and longitudinal study. European Journal of Internal Medicine. 2015, 26(5): 324-329. https://doi.org/10.1016/j.ejim.2015.04.009 |
| [17] | C. Rhee, J. Kim, J.-y. Kim, et al. Clinical Markers Associated with Metabolic Syndrome Among Military Aviators. Aerospace Medicine and Human Performance. 2015, 86(11): 970-975. https://doi.org/10.3357/AMHP.4362.2015 |
| [18] | M. K. Akboga, U. Canpolat, M. Yuksel, et al. Platelet to lymphocyte ratio as a novel indicator of inflammation is correlated with the severity of metabolic syndrome: A single center large-scale study. Platelets. 2016, 27(2): 178-183. https://doi.org/10.3109/09537104.2015.1064518 |
| [19] | J. Ahmadzadeh, B. Mansorian, M. M.-A. Attari, et al. The association between hematological parameters and metabolic syndrome in Iranian men: A single center large-scale study. Diabetes & Metabolic Syndrome. 2018, 12(1): 17-21. https://doi.org/10.1016/j.dsx.2017.07.044 |
| [20] | A. U. Uslu, Y. Sekin, G. Tarhan, et al. Evaluation of Monocyte to High-Density Lipoprotein Cholesterol Ratio in the Presence and Severity of Metabolic Syndrome. Clin Appl Thromb Hemost. 2018, 24(5): 828-833. https://doi.org/10.1177/1076029617741362 |
| [21] | X.-J. Yang, S. Tian, Q.-H. Ma, et al. Leukocyte-related parameters in older adults with metabolic syndrome. Endocrine. 2020, 68(2): 312-319. https://doi.org/10.1007/s12020-020-02243-2 |
| [22] | T. Chen, H. Chen, H. Xiao, et al. Comparison of the Value of Neutrophil to High-Density Lipoprotein Cholesterol Ratio and Lymphocyte to High-Density Lipoprotein Cholesterol Ratio for Predicting Metabolic Syndrome Among a Population in the Southern Coast of China. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 2020, 13: 597-605. https://doi.org/10.2147/DMSO.S238990 |
| [23] | P. M. Nilsson, J. Tuomilehto and L. Rydén. The metabolic syndrome - What is it and how should it be managed? European Journal of Preventive Cardiology. 2019, 26(2_suppl): 33-46. https://doi.org/.1177/2047487319886404 |
| [24] | J. Iqbal, A. Al Qarni, A. Hawwari, et al. Metabolic Syndrome, Dyslipidemia and Regulation of Lipoprotein Metabolism. Current Diabetes Reviews. 2018, 14(5): 427-433. https://doi.org/10.2174/1573399813666170705161039 |
| [25] | E. McCracken, M. Monaghan, S. Sreenivasan. Pathophysiology of the metabolic syndrome. Clinics Dermatology. 2018, 36(1): 14-20. https://doi.org/10.1016/j.clindermatol.2017.09.004 |
| [26] | G. S. Hotamisligil, Inflammation and metabolic disorders. Nature. 2006, 444(7121): 860-867. https://doi.org/10.1038/nature05485 |
| [27] | S. E. Shoelson, J. Lee and A. B. Goldfine. Inflammation and insulin resistance. The Journal of Clinical Investigation. 2006, 116(8): 2308. https://doi.org/10.1172/JCI29069 |
| [28] | C. K. Glass and J. M. Olefsky. Inflammation and lipid signaling in the etiology of insulin resistance. Cell Metabolism. 2012, 15(5): 635-645. https://doi.org/10.1016/j.cmet.2012.04.001 |
| [29] | J. M. Olefsky and C. K. Glass. Macrophages, inflammation, and insulin resistance. Annual Review of Physiology. 2010, 72: 219-46. https://doi.org/10.1146/annurev-physiol-021909-135846 |
| [30] | N. M. Iyengar, A. Gucalp, A. J. Dannenberg et al. Obesity and Cancer Mechanisms: Tumor Microenvironment and Inflammation. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology. 2016, 34(35): 4270-4276. https://doi.org/10.1200/JCO.2016.67.4283 |
| [31] | V. Z. Rocha and P. Libby. Obesity, inflammation, and atherosclerosis. Nature Reviews Cardiology. 2009, 6(6): 399-409. https://doi.org/10.1038/nrcardio.2009.55 |
| [32] | V. Conteduca, O. Caffo, L. Galli, et al. Association among metabolic syndrome, inflammation, and survival in prostate cancer. Urologic Oncology. 2018, 36(5): 240. e1-240. e11. https://doi.org/10.1016/j.urolonc.2018.01.007 |
| [33] | B. D. Horne, J. L. Anderson, J. M. John, et al. Which white blood cell subtypes predict increased cardiovascular risk? Journal of the American College of Cardiology. 2005, 45(10): 1638-1643. https://doi.org/10.1016/j.jacc.2005.02.054 |
APA Style
Pu, T., Cui, M., Li, H., Gao, X., Liu, D. (2024). The Association Between Leukocyte Parameters and Metabolic Syndrome: A Systematic Review and Meta-Analysis. Central African Journal of Public Health, 10(2), 80-89. https://doi.org/10.11648/j.cajph.20241002.13
ACS Style
Pu, T.; Cui, M.; Li, H.; Gao, X.; Liu, D. The Association Between Leukocyte Parameters and Metabolic Syndrome: A Systematic Review and Meta-Analysis. Cent. Afr. J. Public Health 2024, 10(2), 80-89. doi: 10.11648/j.cajph.20241002.13
Share This Article
Twitter
Linked In
Facebook
Copy
Download@article{10.11648/j.cajph.20241002.13,
author = {Ting-yi Pu and Man Cui and Hao-di Li and Xi Gao and Ding-hua Liu},
title = {The Association Between Leukocyte Parameters and Metabolic Syndrome: A Systematic Review and Meta-Analysis},
journal = {Central African Journal of Public Health},
volume = {10},
number = {2},
pages = {80-89},
doi = {10.11648/j.cajph.20241002.13},
url = {https://doi.org/10.11648/j.cajph.20241002.13},
eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.cajph.20241002.13},
abstract = {Background: Metabolic syndrome (MetS) is a cluster of disorders with a high incidence which can lead to the development of type 2 diabetes mellitus and cardiovascular disease. Chronic low-grade inflammation has been implicated in the development of metabolic syndrome. Inflammatory markers such as C-reactive protein have been proved to be associated with MetS, but they are often used in disease diagnosis rather than in routine health screening. Instead, leukocyte is a convenient inflammatory marker. However, the association between leukocyte-related parameters and MetS remains unclear. Therefore, we aimed to perform a systematic review and meta-analysis to evaluate the association between leukocyte parameters and MetS. Materials and Methods: PubMed, EMBASE, Cochrane, and Web of Science were searched for articles published from September 2012 to September 2022 for studies on the association of leukocyte with MetS patients. Outcome data were extracted and the standardized mean difference (SMD) and 95% confidence interval (CI) were calculated. STATA software version 16.0 was utilized to conduct meta-analyses and assess publication bias. Results: A literature search of all major databases retrieved 2661 studies. After screening, 11 studies were analyzed including a total of 13301 MetS patients. Pooled analysis showed that elevated leukocyte level was significantly associated with MetS (SMD = 0.31, 95% CI (0.23-0.38), Z = 8.07, P <0.001). Conclusion: Elevated leukocyte level may be a potentially useful clinical marker for predicting the possibility of developing MetS in healthy populations.
},
year = {2024}
}
TY - JOUR T1 - The Association Between Leukocyte Parameters and Metabolic Syndrome: A Systematic Review and Meta-Analysis AU - Ting-yi Pu AU - Man Cui AU - Hao-di Li AU - Xi Gao AU - Ding-hua Liu Y1 - 2024/03/19 PY - 2024 N1 - https://doi.org/10.11648/j.cajph.20241002.13 DO - 10.11648/j.cajph.20241002.13 T2 - Central African Journal of Public Health JF - Central African Journal of Public Health JO - Central African Journal of Public Health SP - 80 EP - 89 PB - Science Publishing Group SN - 2575-5781 UR - https://doi.org/10.11648/j.cajph.20241002.13 AB - Background: Metabolic syndrome (MetS) is a cluster of disorders with a high incidence which can lead to the development of type 2 diabetes mellitus and cardiovascular disease. Chronic low-grade inflammation has been implicated in the development of metabolic syndrome. Inflammatory markers such as C-reactive protein have been proved to be associated with MetS, but they are often used in disease diagnosis rather than in routine health screening. Instead, leukocyte is a convenient inflammatory marker. However, the association between leukocyte-related parameters and MetS remains unclear. Therefore, we aimed to perform a systematic review and meta-analysis to evaluate the association between leukocyte parameters and MetS. Materials and Methods: PubMed, EMBASE, Cochrane, and Web of Science were searched for articles published from September 2012 to September 2022 for studies on the association of leukocyte with MetS patients. Outcome data were extracted and the standardized mean difference (SMD) and 95% confidence interval (CI) were calculated. STATA software version 16.0 was utilized to conduct meta-analyses and assess publication bias. Results: A literature search of all major databases retrieved 2661 studies. After screening, 11 studies were analyzed including a total of 13301 MetS patients. Pooled analysis showed that elevated leukocyte level was significantly associated with MetS (SMD = 0.31, 95% CI (0.23-0.38), Z = 8.07, P <0.001). Conclusion: Elevated leukocyte level may be a potentially useful clinical marker for predicting the possibility of developing MetS in healthy populations. VL - 10 IS - 2 ER -
Department of Clinical Laboratory, University-Town Hospital of Chongqing Medical University, Chongqing, China
Department of Clinical Laboratory, University-Town Hospital of Chongqing Medical University, Chongqing, China
College of Laboratory Medicine, Chongqing Medical University, Chongqing, China
Department of Clinical Laboratory, University-Town Hospital of Chongqing Medical University, Chongqing, China
